FDA Inspection 993214 — Vitalant Specialty Laboratories And Therapeutics
The FDA completed an inspection of Vitalant Specialty Laboratories And Therapeutics on Oct 26, 2016 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 26, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Chicago, IL (United States)